Trial · NCT07882875
Registered outcomes13
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 13 of 13
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Incidence of Ipsilateral Ischemic Stroke and/or Transient Ischemic Attack | From baseline through 24 months | Number and proportion of participants who experience at least one ipsilateral ischemic stroke and/or transient ischemic attack during prospective follow-up. Events will be evaluated using clinical and available neuroimaging data, with consideration of alternative cerebrovascular mechanisms. |
| Secondary | Change in Montreal Cognitive Assessment (MoCA) Score | Baseline through 24 months | Change from baseline in cognitive performance measured using the Montreal Cognitive Assessment (MoCA). Higher scores indicate better cognitive performance. |
| Secondary | Change in Frontal Assessment Battery (FAB) Score | Baseline through 24 months | Change from baseline in frontal and executive cognitive function measured using the Frontal Assessment Battery (FAB). Higher scores indicate better frontal and executive function. |
| Secondary | Change in Trail Making Test (TMT) Performance | Baseline through 24 months | Change from baseline in Trail Making Test performance measured by completion time during prospective follow-up. Longer completion time indicates poorer test performance. |
| Secondary | New or Progressive Structural Cerebral Abnormalities on MRI | Baseline through 24 months | Number and proportion of participants with at least one new or progressive structural cerebral abnormality on magnetic resonance imaging compared with baseline imaging, including predefined study-relevant signs of cerebral ischemic or vascular injury. |
| Secondary | Change in Serum Neurofilament Light Chain Level | Baseline through 24 months | Change from baseline in serum neurofilament light chain (sNfL) concentration during prospective follow-up. |
| Secondary | Change in Glial Fibrillary Acidic Protein Level | Baseline through 24 months | Change from baseline in circulating glial fibrillary acidic protein (GFAP) concentration during prospective follow-up. |
| Secondary | Change in Anti-NR2 Antibody Level | Baseline through 24 months | Change from baseline in circulating anti-NR2 antibody level during prospective follow-up. |
| Secondary | Change in Modified Rankin Scale (mRS) Score | Baseline through 24 months | Change from baseline in functional status measured using the modified Rankin Scale (mRS). Higher scores indicate greater disability. |
| Secondary | Change in SF-36 Health-Related Quality of Life Score | Baseline through 24 months | Change from baseline in health-related quality of life measured using the 36-Item Short Form Health Survey (SF-36) according to the study assessment schedule. |
| Secondary | Change in VascuQoL-6 Score | Baseline through 24 months | Change from baseline in vascular disease-related quality of life measured using the VascuQoL-6 questionnaire. Higher scores indicate better health-related quality of life. |
| Secondary | Patency of the Reconstruction | Baseline through 24 months | Number and proportion of participants in the surgical cohort with a patent reconstructed carotid artery segment as assessed by duplex ultrasound during follow-up. |
| Secondary | Vascular Events in the Surgical Cohort | Baseline through 24 months | Number and proportion of participants in the surgical cohort experiencing at least one predefined perioperative or late vascular event during follow-up. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT07882875/registered